TABLE 1.
Bacterium, bacteriophage, and plasmid data
| Organism | Origin/pertinent feature(s) | Reference(s) or source | EMBL accession no. |
|---|---|---|---|
| Bacteria | |||
| C-1a | Prototrophic E. coli C strain | 35 | |
| C-1920 | C-1a lysogenized with WΦ | 18 | |
| TD204 | C-1a lysogenized with HK109 | 14 | |
| MG1655 | E. coli K-12 strain | 11 | NC_000913 |
| SCRI1043 | E. carotovora subsp. atroseptica strain | 3 | NC_0045447 |
| ECOR4 | Human, Iowa | 28 | AM159080 |
| ECOR5 | Human, Iowa | 28 | AM159064 |
| ECOR7 | Orangutan, Wash. | 28 | AM159054 |
| ECOR10 | Human, Sweden | 28 | AM159065 |
| ECOR12 | Human, Sweden | 28 | AM159076 |
| ECOR15 | Human, Sweden | 28 | AM159078 |
| ECOR30 | Bison, Canada | 28 | AM159055 |
| ECOR31 | Leopard, Wash. | 28 | AM159056 |
| ECOR44 | Cougar, Wash. | 28 | AM159067 |
| ECOR45 | Pig, Indonesia | 28 | AM159057 |
| ECOR46 | Ape, Wash. | 28 | AM159079 |
| ECOR48 | Human, Sweden | 28 | AM159058 |
| ECOR53 | Human, Iowa | 28 | AM159070 |
| ECOR58 | Lion, Wash. | 28 | AM159059 |
| ECOR59 | Human, Mass. | 28 | AM159071 |
| ECOR61 | Human, Sweden | 28 | AM159072 |
| ECOR62 | Human, Sweden | 28 | AM159073 |
| ECOR64 | Human, Sweden | 28 | AM159074 |
| ECOR67 | Goat, Indonesia | 28 | AM159066 |
| Bacteriophages | |||
| 18 | E. coli clinical isolate, Paris, France | 20 | AM159068 |
| 299 | E. coli clinical isolate, Paris, France | 17, 20 | AM159053 |
| L-413C | NAa | Elliot et al.b | NC_004745 |
| HK109 | E. coli clinical isolate, Hong Kong | 14 | AM159069 |
| HK111 | E. coli clinical isolate, Hong Kong | 14 | AM159062 |
| HK113 | E. coli clinical isolate, Hong Kong | 14 | AM159081 |
| HK114 | E. coli clinical isolate, Hong Kong | 14 | AM159063 |
| HK239 | Cow dung, Hong Kong | 14 | AM159082 |
| HK240 | Cow dung, Hong Kong | 14 | AM159051 |
| HK241 | Human feces, Hong Kong | 14 | AM159052 |
| P2 | Lisbonne and Carrère E. coli strain | 5 | AF063097 |
| P2 Hy dis | Recombinant between P2 and a defective P2-like prophage in an E. coli B strain | 4, 12, 13 | AJ306907 |
| PK | E. coli strain K235 | 21 | AM159049 |
| WΦ | E. coli strain W | 18, 29 | NC_005056 |
| ΦD124 | Clinical isolate, Los Angeles, Calif. | 9 | AM159060 |
| ΦD145 | Clinical isolate, Los Angeles, Calif. | 9 | AM159077, |
| AM158280 | |||
| ΦD160 | Clinical isolate, Los Angeles, Calif. | 9 | AM159075 |
| ΦD252 | Clinical isolate, Los Angeles, Calif. | 9 | AM159061 |
| ΦD266 | Clinical isolate, Los Angeles, Calif. | 9 | AM159050 |
| Plasmids | |||
| pET-16b | Expression vector | Novagen Inc. | |
| pEE900 | pET-16b derivative with the WΦ C gene | 22 | |
| pEE2050 | pET-16b derivative with the P2-EC4 C gene | This work |
a
NA, not applicable.
b
J. M. Elliott, A. A. Filippov, V. V. Kutyrev, A. G. Bobrov, O. A. Kirillina, V. L. Motin, P. S. Chain, and E. Garcia, unpublished data.